Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE\CANDESARTAN CILEXETIL Cause Hepatic function abnormal? 5 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic function abnormal have been filed in association with AMLODIPINE\CANDESARTAN CILEXETIL. This represents 5.4% of all adverse event reports for AMLODIPINE\CANDESARTAN CILEXETIL.

5
Reports of Hepatic function abnormal with AMLODIPINE\CANDESARTAN CILEXETIL
5.4%
of all AMLODIPINE\CANDESARTAN CILEXETIL reports
0
Deaths
5
Hospitalizations

How Dangerous Is Hepatic function abnormal From AMLODIPINE\CANDESARTAN CILEXETIL?

Of the 5 reports, 5 (100.0%) required hospitalization.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE\CANDESARTAN CILEXETIL. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE\CANDESARTAN CILEXETIL Cause?

Dizziness (36) Bradycardia (33) Pain (33) Anxiety (30) Fall (30) Nocturia (30) Pollakiuria (30) Ataxia (29) Balance disorder (29) Central nervous system lesion (29)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Related Pages

AMLODIPINE\CANDESARTAN CILEXETIL Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal AMLODIPINE\CANDESARTAN CILEXETIL Demographics